Intelligent Bio Solutions Inc. Expands Drug Testing System to Australian Waste Management Sector

The deployment of Intelligent Bio Solutions Inc.'s (NASDAQ: INBS) fingerprint drug testing system across Managed Waste Service (MWS) operations in New South Wales represents a pivotal shift in how safety-critical industries approach drug screening. This innovative, non-invasive technology, which delivers results in under ten minutes, is poised to enhance workplace safety by enabling rapid, on-site testing for pre-employment, random, and for-cause purposes. The system's introduction across over 20 remote land clearing and green waste sites underscores its scalability and the growing demand for efficient, hygienic drug testing solutions.

This expansion into the Australian waste management sector highlights the global applicability of INBS's technology, which is already in use by over 450 organizations across 24 countries. The fingerprint-based system's ability to screen for recent use of drugs such as opiates, cocaine, methamphetamine, and cannabis without disrupting field operations offers a significant advantage for industries where safety and efficiency are paramount. The adoption by MWS, a leading waste management provider, signals confidence in the system's potential to revolutionize drug testing protocols in safety-critical environments.

The implications of this deployment extend beyond the immediate benefits to MWS and its employees. It sets a precedent for the adoption of non-invasive, rapid drug testing technologies across industries worldwide, potentially leading to safer workplaces and more efficient operational practices. As INBS continues to expand its reach, the broader applications of its fingerprint sweat analysis technology in additional fields could further transform portable testing, offering new possibilities for employers and organizations committed to maintaining high safety standards.